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Abstract
Background: Temperature is a frequently used parameter to describe the predicted size of
lesions computed by computational models. In many cases, however, temperature correlates
poorly with lesion size. Although many studies have been conducted to characterize the
relationship between time-temperature exposure of tissue heating to cell damage, to date these
relationships have not been employed in a finite element model.
Methods: We present an axisymmetric two-dimensional finite element model that calculates cell
damage in tissues and compare lesion sizes using common tissue damage and iso-temperature
contour definitions. The model accounts for both temperature-dependent changes in the electrical
conductivity of tissue as well as tissue damage-dependent changes in local tissue perfusion. The data
is validated using excised porcine liver tissues.
Results:  The data demonstrate the size of thermal lesions is grossly overestimated when
calculated using traditional temperature isocontours of 42°C and 47°C. The computational model
results predicted lesion dimensions that were within 5% of the experimental measurements.
Conclusion: When modeling radiofrequency ablation problems, temperature isotherms may not
be representative of actual tissue damage patterns.
Introduction
The mitigation of primary and metastatic tumors by radi-
ofrequency ablation is a developing research area. The
goal of ablation is to necrose treatment volumes by raising
the temperature of targeted tissues. Ablation probes are
inserted percutaneously, laparoscopically, or during sur-
gery into cancerous tumors. Once positioned, high fre-
quency alternating current (450–550 kHz) is delivered
through an uninsulated electrode into the surrounding
tissues to a dispersive ground pad that is applied to the
patient. The electromagnetic energy is converted to heat
by resistive heating.
While the usage of radiofrequency ablation devices is well
established, efforts to optimize treatment strategies are
ongoing. An important consideration in optimizing abla-
tion is determining what treatment volumes are necessary
and acceptable. In liver ablation, for example, treatment
volumes generally extend a centimeter beyond the dimen-
sions of a tumor [1-3]. Since the liver possesses regenera-
tive characteristics, it is more critical to insure that
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necrosis is achieved in 100% of the cancerous cell volume
than to minimize damage to healthy tissues. In contrast, a
centimeter margin in cardiac ablation is generally unac-
ceptable since many vital substructures are in close
proximity.
The growth of ablation lesions remains a central issue in
the development of radiofrequency ablation devices.
Knowing the expected shape of lesions is essential for
treatment planning and procedure optimization. To date,
many approaches have been attempted to characterize
lesion size. The results have varied widely. Ablation
lesions generated in vitro and in vivo in animal models
show wide variations, since many of the key parameters
(i.e. tissue perfusion) cannot be controlled [4,5]. In addi-
tion, the boundaries of lesions in animal models are often
"fuzzy" and are subject to interpretation. Computational
modeling is a valuable tool in the optimization process,
since it allows the systematic examination of the various
parameters affecting the outcome of ablation. However,
most computational models fail to capture essential phys-
iologic phenomena.
Many computational studies have been reported in the lit-
erature to predict the growth of lesion size during ablation
[6-19]. However, the majority of these models do not
directly calculate lesion size. Surrogate endpoints, such as
temperature [20-22] and thermal dosing [23] are calcu-
lated and are interpreted as being equivalent to lesion
size. In many cases, these surrogate endpoints do not cor-
relate well with clinical outcome and vary considerably.
The microwave hyperthermia literature, for example, cites
42 degrees Celsius as the point at which thermal damage
occurs to tissues [24,25]. In the cardiac ablation literature,
47 degrees Celsius is generally accepted as the onset of tis-
sue damage [23,24,26,27]. Neither of these values can be
derived directly from gross histological measurements of
lesion size, since the tissue pathology does not provide a
record of temperature. Many computational studies jus-
tify these surrogate endpoints by showing a high correla-
tion between temperature isotherms and lesion size.
However, temperature isotherms and lesion size have
never actually been shown to be equivalent.
Several investigators have demonstrated that tissue dam-
age is a function of both temperature and time [28-30]. As
tissue temperature is increased, the amount of time neces-
sary to achieve a threshold of damage decreases. Tissue
damage can be characterized using the Arrhenius equa-
tion which relates temperature and exposure time using a
first order kinetics relationship. Data from experimental
studies, where tissues are exposed to uniform tempera-
tures for controlled time intervals, are fit to the Arrhenius
equation to determine the frequency factor A(s-1), and the
activation energy ∆E (J mol-1). Arrhenius parameters have
been determined in skin [31-35], artery [36,37], blood
[38-40], pancreas [41,42], heart [43], cornea [44-46],
muscle [47], prostate [48], ovary [49], kidney [50-52], and
liver [30,52,53]. For a specified exposure temperature and
time, the fit parameters A and ∆E determine the amount
of cell damage incurred for a specific tissue type. In com-
bination with computational modeling techniques, it is
then possible to calculate the distribution of cell damage
surrounding ablation probes.
In this study, we compare the temperature distribution
and tissue necrosis patterns for a hepatic ablation probe at
body temperatures. At each time step, the specific absorp-
tion rate (SAR), temperature, and the tissue damage are
calculated. The level of tissue perfusion is varied for the
models to determine the maximum variation in lesion
size resulting from a typical ablation. These data are vali-
dated experimentally using an ablation probe in liver
tissue.
Methods
Radiofrequency ablation probes operate between 460–
550 kHz. At these frequencies, the wavelength of the elec-
tromagnetic energy is several orders of magnitude larger
than the size of the ablation electrodes. Thus, the primary
mode of energy transfer is through electrical conduction
and can be modeled as a coupled quasistatic electrical
conduction and heat conduction problem. The electric
field is solved by using Laplace's equation,
∇·[σ(T)∇V] = 0   (Eq.1)
where ∇ is the gradient operator, σ (T) is the temperature-
dependent conductivity (Siemens/meter), and V is the
electric potential (Volts). Temperature is solved by using a
modified Pennes bioheat equation [54],
where ρ is the density, 1060 kg/m3 [55]; C is the heat
capacity of tissues, 3600 J/kg-K [55]; k is the heat conduc-
tion coefficient, 0.502 W/K-m [55]; ρb is the density of
blood, 1000 kg/m3 [9]; Cb is the heat capacity of blood,
4180 J/kg-K [9];α is a tissue state coefficient; ω is the
blood perfusion coefficient, 6.4 × 10-3 sec-1 [9];Tamb is the
ambient body temperature, 37°C; and Qm is the meta-
bolic heat source term. For all cases, we assumed that the
metabolic heat source was insignificant. The tissue state
coefficient (α) ranges from 0–1 depending on the local
level of tissue damage
At each time step, the cumulative damage integral is com-
puted using the well established Arrhenius equation
ρσ ρ α ω C
dT
dt
kT V C T T Q bb a m b m =∇⋅ ∇ () +∇ − − () + ()
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where Ω(t) is the degree of tissue injury, c(t) is the concen-
tration of living cells, R is the universal gas constant, A is
a "frequency" factor for the kinetic expression (s-1), and
∆E  is the activation energy for the irreversible damage
reaction (J-mol-1) [50]. The kinetic parameters account for
morphologic changes in tissue relating to the thermal deg-
radation of proteins [56]. The parameters A and ∆E are
dependent on the type of tissue and have been character-
ized for liver tissues by Jacques et. al. (A = 7.39 × 1039 s-1
and ∆E = 2.577 × 105 J-mol-1) [52]. In the context of finite
element modeling of tissue damage, a damage integral of
Ω = 1, corresponds to a 63% percent probability of cell
death at a specific point. A damage integral of Ω = 4.6, cor-
responds to 99% percent probability of cell death at a
point in the model. The significance of Ω = 1 has been
reported as the point at which tissue coagulation first
occurs [36]. Once tissue coagulation occurs, tissue per-
fusion ceases. This corresponds to a tissue state coefficient
of α = 0. Intermediate levels of the tissue state coefficient
are calculated as α = 1/exp(Ω).
Figure 1 shows a diagram of a typical needle ablation elec-
trode used in clinical practice for hepatic tumor ablation.
The probe is 6.0 cm long with a diameter of 0.15 cm. The
distal 2.0 cm of the probe is uninsulated and the proximal
4.0 cm of the probe is covered with a thin electrically insu-
lating material. Figure 2 shows a three-dimensional repre-
sentation of the axisymmetric two-dimensional geometry
of the model. The active portion of the probe is situated in
the center of a cylindrical model that is 6.0 cm in radius
and 12.0 cm in height. Electrical and thermal properties of
liver are used in the model to simulate a fully-embedded
insertion of the needle electrode. The electrical properties
of tissue are assumed to be temperature dependent and
solved according to Chang [57], where the electrical con-
ductivity appears as
σ(T,N) = σ(25,N) {1.000-1.962 × 10-2∆ + 8.08 × 10-5∆2
- N∆ [3.020 × 10-5 + 3.922 × 10-5∆ + N(1.721 × 10-5∆
- 6.584 × 10-6∆)]}   (Eq.4)
where
σ (25,N) = N [10.394-2.3776 N + 0.68258 N2 - 9.13538
N3 + 1.0086 × 10-2 N4]
;N is the normality of an electrically equivalent sodium
chloride solution, N = 0.0111; and Ä = 25-T, which pro-
duces an equivalent electrical conductivity of liver tissues
at 37°C (approximately 0.134 S/m). The thermal proper-
ties of liver used in the model were acquired from
Tungjitkusolmun et al.[9] and Duck [55].
A source voltage (Vo) is applied to the conducting tip of
the ablation probe. The outer surface of the model serves
as an electrical ground return (V = 0). An electrically insu-
lating boundary condition is applied to the non-conduct-
ing portions of the probe such that n·(σ∇ V) = 0; where n
is the unit vector normal to the surface, σ is the electrical
conductivity, and V is the voltage at the insulating surface.
A thermal boundary condition of T = Tamb is applied to the
outer surfaces of the model to simulate ambient tempera-
ture. Since the thermal mass of the probe is small com-
pared to the surrounding tissue, we assumed that heat
conduction into the probe itself was minimal. Thus, all
other surfaces of the ablation probe are considered to have
a thermally insulating boundary condition such that n·(k
∇ T) = 0.
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Ablation Probe Geometry Figure 1
Ablation probe geometry diagram of a single needle ablation electrode that is used for hepatic tumor ablation. Therapeutic 
treatment is achieved by applying a source voltage to the conducting tip. A conducting pad applied to the patient skin serves as 
an electrical ground return.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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A hybrid finite element model was developed using Fem-
lab (Comsol, Burlington MA, USA) and Matlab (Math-
works, Natick MA, USA) to calculate temperature and
tissue damage. While conventional finite element models
effectively solve field solutions using a nonuniform geo-
metrical mesh, tissue exposure calculations are integrated
at each point in the model over the course of ablation and
are more easily calculated using uniform rectilinear grids.
As shown in Figure 3, Femlab is used to solve the coupled
electromagnetic and heat conduction equations simulta-
neously at each timestep. This is done to insure that the
temperature-dependent electrical conductivity is updated
with each iterative calculation of temperature for a given
timestep. The converged temperature is mapped from the
finite element mesh into a rectilinear grid, which is passed
into the Matlab environment. The amount of tissue dam-
age occurring at each timestep is calculated using the
Arrhenius equation and tracked at each point in the
model. Once the level of damage exceeds 63% cell dam-
age, it is assumed that tissue coagulation has occurred,
causing a cessation in tissue perfusion. The 63% cell dam-
age point is historically used because it corresponds to the
earliest onset of visible tissue coagulation. A rectilinear
grid containing the perfusion characteristics at each point
in the model is mapped back into the finite element mesh
and used in subsequent Femlab calculations. The rectilin-
ear grid of temperature is also used to calculate the change
in the electrical conductivity which is an explicit function
Model Geometry Figure 2
Model geometry three dimension representation of the axisymmetric two-dimensional finite element model. All external sur-
faces of the cylindrical model serve as the electrical ground and are at body temperatures (37°C). The entire ablation probe is 
assumed to be thermally insulating.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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of temperature. This data is also mapped back into the
finite element mesh and is used to change the electromag-
netic sourcing characteristics. Augmented matrices are
used to insure that calculations made on the geometric
borders of the Femlab model are interpolated correctly.
Given the axial symmetry of the problem, we used a 2D-
axisymmetric mesh consisting of 13,641 nodes and
26,880 elements. The Femlab 'Fldaspk' ordinary differen-
tial equation solver was used to achieve convergence. This
is a robust variant of the traditional ODE15s stiff differen-
tial equation solver used in solving finite element prob-
lems in Matlab. Ablations were simulated at source
voltages of 0, 2.5, 5, 7.5, 10, 12.5, 15, 17.5, 20, 22.5, 25,
27.5, and 30 volts. For each of the source voltages, we var-
ied the initial level of tissue perfusion at 0%, 20%, 40%,
60%, 80%, and 100% normal tissue perfusion (6.4 × 10-3
cubic meters of blood/ cubic meter of tissue/ second) [9].
Ambient tissue temperature was assumed to be 37°C. The
model simulates a 15 minute ablation and updates tissue
parameters at 2 second timestep intervals. Once the 15
minute ablation has ended, the model continues to solve
solutions for 15 minutes post-ablation. For each simula-
tion, the electric field (E), the current density (J), the tem-
Computational Technique Figure 3
Computational technique diagram of data flow used in a hybrid finite element model implemented in Femlab/Matlab to calculate 
temperature and tissue damage. The electric field and temperature are solved simultaneously in Femlab (blue blocks). The data 
structure is changed from finite element meshing to rectilinear gridding so that the resulting temperature can be used to calcu-
late tissue exposure and electrical conductivity change in Matlab (orange blocks). A tissue damage level of 63% corresponds to 
the onset of tissue necrosis and is associated with a cessation in local blood flow. The Matlab results are then imported into 
Femlab as inputs for calculation at the next time step.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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perature (T), and the tissue damage (D) were calculated.
All calculations were implemented on a Dual 3.02 GHz
Xeon processor workstation with 4 GByte RAM. Each sim-
ulation takes approximately 3 hours to run.
Experimental Validation
To validate the computational model, experimental meas-
urements were made in 6 freshly excised porcine liver sec-
tions. A single needle ablation probe with a 2 cm
uninsulated tip was inserted 3 cm into each liver tissue.
Since commercial RF ablation generators operate using
either constant temperature or constant power feedback
algorithms, an experimental constant voltage RF genera-
tor (500 kHz) was used [5]. Tissue samples were allowed
to equilibrate to room temperature (approximately 22°C)
prior to the start of ablation. Two samples were ablated at
20 volts for 15 minutes. After allowing the tissue to cool
for an additional 15 minutes, the probes were removed
and the tissue was bisected to expose the lesion. The tis-
sues were immediately placed in a 1% 2,3,5-triphe-
nyltetrazolium chloride (red) solution for 20 minutes to
stain for tissues containing active dehydrogenase, an indi-
cator of cell viability [58,59]. This stains healthy tissue
brick red, leaving the ablated region a pale grey color. The
maximum width and depth of the macroscopically pale
ablated regions were measured. This procedure was
repeated for two samples at 25 volts and for the last two
samples at 30 volts.
Computational model calculations were made at 20, 25,
and 30 volts following the same experimental protocol.
Ambient temperature for these calculations was 22°C
instead of the 37°C temperature used in the main simula-
tions. The calculated lesion sizes were directly compared
with the measurements in tissue.
Results
Table 1 shows the maximum temperatures attained in tis-
sue for the computational models for a range of voltages
(2.5–30 Volts) and tissue perfusion rates (0–100% nor-
mal tissue perfusion.). The table shows a nonlinear rela-
tionship between the source voltage and the maximum
temperature that results from the use of a temperature-
dependent electrical conductivity. The maximum varia-
tion in the temperature data for a given source voltage did
not exceed 17%. The data show that the rate of tempera-
ture increase accelerates as a function of the source volt-
age. As the level of tissue perfusion increases, tissue
temperature decreases.
Table 2 shows the maximum electrical conductivity in the
tissue after heating for 15 minutes at a variety of source
voltages. All tissues initially have an electrical conductivity
of 0.144 S/m at 37°C. The data show that tissue electrical
conductivity is primarily a function of the source voltage,
changing 320% over the course of a 15 minute ablation
using a 30 volt source. With normal tissue perfusion (6.4
× 10-3 mb
3/ mt
3/s), the electrical conductivity changes as
much as 260% using a 30 volt source. The electrical con-
ductivity is indirectly a function of tissue perfusion since
tissue perfusion is zero in the necrosed treatment volume.
Tissue perfusion lowers the tissue temperature outside the
treatment volume which helps to conduct heat away from
temperatures within the ablated area..
Table 1: Maximum Temperature (Degrees Celsius)1 Values represent the maximum temperature attained in tissue for the 
computational models.
Source Voltage 
(Volts)
0%2 Perfusion (0.0 
× 10-3 mb
3/mt
3/s)
20%2 Perfusion (1.3 
× 10-3 mb
3/mt
3/s)
40%2 Perfusion (2.6 
× 10-3 mb
3/mt
3/s)
60%2 Perfusion (3.8 
× 10-3 mb
3/mt
3/s)
80%2 Perfusion (5.1 
× 10-3 mb
3/mt
3/s)
100%2 Perfusion (6.4 
× 10-3 mb
3/mt
3/s)
2.5 37.3 37.3 37.2 37.2 37.2 37.2
5.0 38.6 38.5 38.4 38.3 38.2 38.2
7.5 41.0 40.6 40.3 40.1 40.0 39.9
10.0 44.3 43.6 43.1 42.8 42.5 42.3
12.5 48.8 47.7 46.9 46.3 45.8 45.4
15.0 54.6 52.9 51.6 50.7 50.0 49.4
17.5 62.0 59.5 57.7 56.2 55.2 54.3
20.0 71.1 67.9 65.5 63.4 61.9 60.7
22.5 82.4 78.6 75.4 73.0 70.7 69.0
25.0 96.1 91.8 88.0 84.8 82.1 79.7
27.5 112.73 107.83 103.43 99.5 96.1 93.4
30.0 132.53 126.93 121.83 117.43 113.43 109.93
1 – The maximum temperature for the case of 0% perfusion was located along the center of the conducting electrode. In all other cases, the 
maximum temperature occurred at the tip of the probe; 2 – The units for tissue perfusion are cubic meters of blood (mb
3) per cubic meter of tissue 
(mt
3) per second; 3 – These temperatures do not account for energy loses associated with tissue desiccation or gas formation.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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Table 3 shows the maximum SAR computed for a range of
voltages and tissue perfusion rates. The SAR is defined as
SAR = σ /ρ*|E|2, where σ is the electrical conductivity, ρ is
the tissue density, and |E| is the magnitude of the electric
field. The data shows that the SAR is highest with increas-
ing source voltage with no tissue perfusion. Initially, this
seems counterintuitive as one would expect a higher max-
imum SAR for perfused flows, where a greater amount of
power is needed to compensate for the convective heat
loss. This observation can be explained by the large
changes in the electrical conductivity (Table 2). Since
higher temperatures are achieved for cases with no tissue
perfusion, the change in the electrical conductivity is high-
est with no tissue perfusion. Since, at a given point, the
density and the magnitude of the electric field are essen-
tially constant (<0.02% change), the SAR will vary as a
function of the electrical conductivity only.
Figure 4 shows the tissue temperature and the cell death
penetration into tissue for a 15 minute ablation using a 30
Table 2: Maximum Electrical Conductivity (Siemens/meter)1 Values represent the maximum electrical conductivity attained in tissue 
for the computational models.
Source Voltage 
(Volts)
0%2 Perfusion (0.0 
× 10-3 mb
3/mt
3/s)
20%2 Perfusion (1.3 
× 10-3 mb
3/mt
3/s)
40%2 Perfusion (2.6 
× 10-3 mb
3/mt
3/s)
60%2 Perfusion (3.8 
× 10-3 mb
3/mt
3/s)
80%2 Perfusion (5.1 
× 10-3 mb
3/mt
3/s)
100%2 Perfusion (6.4 
× 10-3 mb
3/mt
3/s)
2.5 0.144 0.144 0.144 0.144 0.143 0.143
5.0 0.147 0.147 0.146 0.146 0.146 0.146
7.5 0.153 0.152 0.151 0.151 0.150 0.150
10.0 0.162 0.160 0.159 0.158 0.157 0.156
12.5 0.173 0.170 0.168 0.167 0.165 0.164
15.0 0.189 0.185 0.181 0.179 0.177 0.175
17.5 0.210 0.203 0.198 0.194 0.191 0.189
20.0 0.238 0.228 0.221 0.215 0.210 0.207
22.5 0.274 0.262 0.251 0.244 0.237 0.232
25.0 0.321 0.306 0.293 0.282 0.273 0.265
27.5 0.383 0.364 0.348 0.334 0.321 0.312
30.0 0.463 0.440 0.419 0.401 0.385 0.372
1 – The maximum electrical conductivity for the case of 0% perfusion was located along the center of the conducting electrode. In all other cases, the 
maximum temperature occurred at the tip of the probe; 2 – The units for tissue perfusion are cubic meters of blood (mb
3) per cubic meter of tissue 
(mt
3) per second.
Table 3: Maximum Specific Absorption Rate (Watts/kg)1 Values represent the maximum specific absorption rate (SAR) attained in 
tissue for the computational models.
Source Voltage 
(Volts)
0%2 Perfusion (0.0 
× 10-3 mb
3/mt
3/s)
20%2 Perfusion (1.3 
× 10-3 mb
3/mt
3/s)
40%2 Perfusion (2.6 
× 10-3 mb
3/mt
3/s)
60%2 Perfusion (3.8 
× 10-3 mb
3/mt
3/s)
80%2 Perfusion (5.1 
× 10-3 mb
3/mt
3/s)
100%2 Perfusion (6.4 
× 10-3 mb
3/mt
3/s)
2.5 645.6 645.3 645.1 644.9 644.8 644.8
5.0 2608 2603 2600 2598 2596 2595
7.5 5966 5940 5924 5912 5903 5896
10.0 10850 10770 10720 10680 10650 10630
12.5 17450 17260 17120 17030 16950 16900
15.0 26030 25620 25330 25120 24970 24860
17.5 36940 36140 35600 35190 34900 34680
20.0 50590 49180 48230 47480 47000 46620
22.5 67470 65210 63520 62510 61610 60990
25.0 88170 84890 82360 80440 78940 77910
27.5 113300 108900 105300 102400 100100 98390
30.0 143400 137700 133000 129000 125700 123000
1 – The maximum current density was always located at the tip of the ablation probe. Therefore, all values listed above are comparable with each 
other; 2 – The units for tissue perfusion are cubic meters of blood (mb
3) per cubic meter of tissue (mt
3) per second.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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volt constant voltage source for perfusion rates ranging
from no perfusion to 100% normal tissue perfusion. The
data show that cell death decreases more rapidly than tis-
sue temperature. At the center of the active electrode, tem-
peratures decrease as a function of the inverse of the
radius squared (1/r2), whereas cell damage exhibits an S-
shaped curve. Figure 4 shows that 63% tissue damage is
roughly correlated with the 60°C isotherm for liver
tissues. Conventional temperature isotherms for tissue
damage for hyperthermia (42°C) and radiofrequency
ablation (47°C) substantially overestimate the size of the
lesions.
Figure 5 shows a plot of tissue temperature and cell dam-
age calculated at a distance of 4 millimeters from the
center of the active electrode for a 15 minute ablation
using a 30 volt constant voltage source. Temperature
decrease and cell damage that occurs after the ablation is
monitored for an additional 15 minutes. The data show
that near the electrode, tissue damage will reach 100%
well within the first few minutes of energy application.
For cases of no tissue perfusion, 100% tissue damage
occurs after 5 minutes at a distance of 4 millimeters. For
cases with normal tissue perfusion, 100% tissue damage
occurs approximately 8 minutes into the ablation. At a
distance of 10 millimeters from the center of the active
electrode under the same conditions (Figure 6), the data
Tissue temperature and cell death penetration for a 15 minute ablation using a 30 volt constant voltage source Figure 4
Tissue temperature and cell death penetration for a 15 minute ablation using a 30 volt constant voltage source. Simulation 
results for a 15 minute ablation using a 30 volt constant voltage source measured from the center of the active electrode. The 
graph shows temperature (solid) and cell death (dotted) penetration into liver tissue for a range of tissue perfusion rates. The 
units for tissue perfusion are cubic meters of blood (mb
3) per cubic meter of tissue (mt
3) per second (s).BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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show that tissue damage will not always reach 100%. For
the case of no perfusion, 100% cell damage is reached a
minute after the termination of radiofrequency energy. In
cases with varying levels of tissue perfusion, cell damage is
significantly reduced and, in some cases, insignificant.
Although the overall temperatures are lower at 10 millim-
eters than at 4 millimeters, temperatures near 60°C are
reached but do not result in complete tissue damage
because the length of time in which the tissue is exposed
is not sufficient.
Figure 7 and 8 show comparisons of temperature distribu-
tion and lesion size development with no tissue perfusion
(Figure 7) and with normal tissue perfusion (Figure 8) for
a 30 volt constant voltage source ablation at 1, 3, 5, 10
and 15 minutes. The data demonstrate that the shapes of
the temperature isotherms do not correlate well with tis-
sue damage profiles. Tissue perfusion greatly affects the
size of the resulting ablated region. At 15 minutes, lesion
volumes are 267% larger without perfusion than with tis-
sue perfusion. Figures 9 and 10 show a comparison of the
temperature distribution and lesion size development
with no tissue perfusion (Figure 9) and with normal tissue
perfusion (Figure 10) at 1, 3, 5, 10, and 15 minutes fol-
lowing a 15 minute constant 30 volt ablation. In the case
of no tissue perfusion, the lesion size continues to grow
Tissue temperature and cell death at a distance of 4 millimeters from the center of the active electrode using a 30 volt constant  voltage source Figure 5
Tissue temperature and cell death at a distance of 4 millimeters from the center of the active electrode using a 30 volt constant 
voltage source. Ablation simulation results attained 4 millimeters from the center of the active electrode for a 15 minute abla-
tion using a 30 volt constant voltage source. The graph shows temperature (solid) and cell death (dotted) penetration into liver 
tissue for a range of tissue perfusion rates. The units for tissue perfusion are cubic meters of blood (mb
3) per cubic meter of 
tissue (mt
3) per second (s).BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
Page 10 of 19
(page number not for citation purposes)
14% within the first 5 minutes after radiofrequency
energy is terminated. The lack of tissue perfusion prolongs
the time needed to conduct the heat away from tissues
near the surface of the ablation electrode. For cases with
normal tissue perfusion, heat is quickly dissipated by tis-
sue perfusion causing the lesion volume to stabilize in less
than 2 minutes. By definition, the area of coagulative
necrosis has no tissue perfusion. This accounts for the
residual heating pattern within the ablated region as seen
up to 3 minutes following the ablation.
A comparison of lesion volumes with no tissue perfusion
computed using 63% and 100% iso-damage threshold
contours and 42°C, 47°C, 60°C, and 90°C isothermal
contours is presented for the cases of no tissue perfusion
(Table 4) and normal tissue perfusion (Table 5). The sen-
sitivity of the cell damage function (Figure 4) results in
less than 10% differences in the size of lesions calculated
using tissue damage thresholds of 63% and 100% cell
damage. In contrast, volume sizes based on isothermal
contours varies considerably at each temperature. When
using traditional isothermal contours of 42°C and 47°C,
the calculated lesion volumes are grossly overestimated by
500% and 167%, respectively. In both the case of no tis-
sue perfusion and normal tissue perfusion, the 60°C
Tissue temperature and cell death at a distance of 10 millimeters from the center of the active electrode using a 30 volt con- stant voltage source Figure 6
Tissue temperature and cell death at a distance of 10 millimeters from the center of the active electrode using a 30 volt con-
stant voltage source. Ablation simulation results attained 10 millimeters from the center of the active electrode for a 15 minute 
ablation using a 30 volt constant voltage source. The graph shows temperature (solid) and cell death (dotted) penetration into 
liver tissue for a range of tissue perfusion rates. The units for tissue perfusion are cubic meters of blood (mb
3) per cubic meter 
of tissue (mt
3) per second (s).BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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isothermal contour resembles the lesion sizes calculated
using the iso-damage contours.
Table 6 shows a comparison of lesion width and depth
computed using 63% and 100% iso-damage threshold
contours and 42°C, 47°C, 60°C, and 90°C isothermal
contours. The data show overestimations of 30–77% in
the width and 18–54% in the depth of lesions when using
traditional isothermal temperatures for a 15 minute abla-
tion with no perfusion. Table 7 shows that in cases with
normal tissue perfusion, calculations using traditional
isothermal contours results in overestimations of 25–88%
in the width and 15–41% in the depth of lesions.
To validate the computational model, ablation experi-
ments were performed at room temperature (22°C) in
excised porcine liver tissue using 20, 25, and 30 volt con-
stant voltage radiofrequency sources (500 kHz). Ablations
were made for a 15 minute exposure time. Figure 11
shows that no visible lesion can be seen in tissues where
the 20 volt constant voltage ablation was performed, as
predicted by the computational simulation. A lesion that
was approximately 10 millimeters in width and 22 mm in
depth resulted from the 30 volt constant voltage ablation.
Table 8 shows a high correlation between the
computational data calculated at 22°C and the experi-
mental results.
Discussion
To date, several computational studies have been per-
formed to described the rate of lesion growth in radiofre-
quency ablation applications. In many cases, these studies
use surrogate endpoints such as temperature isotherms
and thermal dosing to calculate equivalent expressions for
lesion size. While many models exists that account for far-
more elaborate parameters such as tissue perfusion
Comparison of temperature and lesion size development with no tissue perfusion for a 30 volt constant voltage source  ablation Figure 7
Comparison of temperature and lesion size development with no tissue perfusion for a 30 volt constant voltage source abla-
tion. Ablation simulation results for a 30 volt constant voltage source ablation with no tissue perfusion. The results on the top 
half of the figure represent the temperature distribution surrounding the ablation probe in degrees Celsius. The results on the 
bottom half of the figure represent the percent tissue damage. The numbers listed at the bottom are the lesion volume sizes 
computed from the 63% cell damage isocontours at each time interval shown.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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through large blood vessels, the interpretation of such
models is difficult since most do not account for transient
changes in tissue properties and often report tissue tem-
perature only [6-9,12,14-19,56,57,60]. Several studies
have identified that both exposure time and temperature
contribute to tissue damage, however, few have actually
calculated tissue damage. Those that do, have not allowed
tissue damage to transiently influence the electrical and
thermal properties of tissues [6,56].
In this study, we created a computational simulation that
tested some of the basic assumptions made in modeling
lesion growth problems. We developed a model where tis-
sue perfusion and the electrical conductivity are allowed
to vary at each time step and spatial position as a function
of tissue damage and temperature. These simulations are
significantly more time-consuming since gross simplifica-
tions to heating mechanisms are not made. Although our
model geometry is simpler than others that appear in the
literature, we chose to ignore large vessels since their posi-
tion and impact are highly variable. We chose a simpler
geometry so that the impact of damage-dependent tissue
perfusion and temperature-dependent electrical conduc-
tivity could be assessed more directly.
The damage-dependent tissue perfusion accounts for
physiological observations of tissue coagulation and local
cessation of blood flow. Unlike thermal dosing, where
thermal injury is calculated globally over the entire dura-
tion of an ablation, tissue damage is calculated at every
time step. The intermediate tissue damage that results at
every timestep influences the local tissue perfusion and
creates a moving boundary condition which changes the
local heat sink properties. Ignoring the intermediate
Comparison of temperature and lesion size development with normal tissue perfusion (6.4 × 10-3 mb
3/mt
3/s) for a 30 volt con- stant voltage source ablation Figure 8
Comparison of temperature and lesion size development with normal tissue perfusion (6.4 × 10-3 mb
3/mt
3/s) for a 30 volt con-
stant voltage source ablation. Ablation simulation results for a 30 volt constant voltage source ablation with normal tissue per-
fusion (6.4 × 10-3 mb
3/mt
3/s). The results on the top half of the figure represent the temperature distribution surrounding the 
ablation probe in degrees Celsius. The results on the bottom half of the figure represent the percent tissue damage. The num-
bers listed at the bottom are the lesion volume sizes computed from the 63% cell damage isocontours at each time interval 
shown.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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timesteps causes tissue perfusion to remain constant
throughout the entire ablation, which results in an under-
estimation of the true lesion size. The use of temperature-
dependent electrical conductivity greatly affects modeling
results, as the electrical conductivity has been shown to
increase dramatically over the course of tissue heating
[57]. When constant electrical conductivity is used, the
SAR is grossly underestimate, which also results in an
underestimation in lesion size.
An important outcome of this study is the demonstration
that, temperature isotherms and tissue damage patterns
are not synonymous. Traditional use of temperature iso-
therms that are used to define lesion size rely on coagula-
tion temperature for protein (42–47°C) and grossly
overestimate lesion dimensions. Our studies show that
temperature decrease is gradual, while tissue damage
decreases rapidly as a function of distance. It is this sharp
decrease in tissue damage that causes lesion boundaries to
appear fuzzy, as predicted by our model. The results also
demonstrate that ablation lesions continue to grow after
the applied power is terminated. Lesions continue to grow
while temperature envelopes collapse after ablation since
sufficiently high temperature are present to accrue tissue
damage. In nearly all cases, lesions continued to grow sev-
eral minutes following the ablation. A comparison of the
resulting lesion dimensions between fully perfused and
non-perfused tissues show that the lesion width decreases
38–46% and the lesion depth decreases 18–20% when tis-
sue perfusion is accounted for in the model. Previous
studies have shown that tissue perfusion can account for
as much as 50% change in the size of the lesions generated
during ablation [59].
An important observation in this study is the resemblance
of the 60°C isocontour to lesion size. While the 42°C and
Comparison of temperature and lesion size development post ablation with no tissue perfusion for a 30 volt constant voltage  source ablation Figure 9
Comparison of temperature and lesion size development post ablation with no tissue perfusion for a 30 volt constant voltage 
source ablation. Ablation simulation results following a 15 minute ablation without perfusion for a 30 volt constant voltage 
source ablation. The results on the top half of the figure represent the temperature distribution surrounding the ablation 
probe in degrees Celsius. The results on the bottom half of the figure represent the percent tissue damage. The numbers listed 
at the bottom are the lesion volume sizes computed from the 63% cell damage isocontours at each time interval shown.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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Comparison of temperature and lesion size development post ablation with normal tissue perfusion (6.4 × 10-3 mb
3/mt
3/s) for a  30 volt constant voltage source ablation Figure 10
Comparison of temperature and lesion size development post ablation with normal tissue perfusion (6.4 × 10-3 mb
3/mt
3/s) for a 
30 volt constant voltage source ablation. Ablation simulation results following a 15 minute ablation with normal tissue per-
fusion (6.4 × 10-3 mb
3/mt
3/s) for a 30 volt constant voltage source ablation. The results on the top half of the figure represent 
the temperature distribution surrounding the ablation probe in degrees Celsius. The results on the bottom half of the figure 
represent the percent tissue damage. The numbers listed at the bottom are the lesion volume sizes computed from the 63% 
cell damage isocontours at each time interval shown.
Table 4: Lesion Volume with No Tissue Perfusion Values represent the total volume of tissue necroses calculated over the course of 
the simulated ablation using various cell damage thresholds (D) and isothermal temperatures (IT).
Source Voltage 
(Volts)
D = 63% (mm3) D = 100% (mm3) IT = 42°C (mm3)1 IT = 47°C (mm3)1 IT = 60°C (mm3)I T  =  9 0 ° C  ( m m 3)
2 . 5 000000
5 . 0 000000
7 . 5 000000
10.0 0 0 89 0 0 0
12.5 0 0 444 13 0 0
15.0 0 0 942 216 0 0
17.5 9 3 1649 526 6 0
20.0 121 67 2508 915 87 0
22.5 314 242 3549 1414 296 0
25.0 577 495 4860 2070 547 6
27.5 923 809 6452 2866 870 55
3 0 . 01 3 8 81 2 2 88 3 8 63 8 3 01 2 4 3 2 0 2
1 – The 42°C and 47°C isothermal volumes were chosen specifically because they are frequently used to establish damage thresholds in 
hyperthermia and radiofrequency ablation, respectively.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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the 47°C isotemperature contours are poor indicators of
lesion size, 60°C is highly correlated with the lesion vol-
umes. Seemingly, this would suggest that time-intensive
tissue damage calculations need not be made since a crit-
ical temperature of 60°C can be used to identify lesion
size. However, this is only true if the calculated
temperature is a function of both transient changes in tis-
sue perfusion and the electrical conductivity. In the
absence of either of these phenomena, lesion sizes calcu-
lated at 60°C would underestimate lesion size.
The validation data demonstrate that the model accu-
rately accounts for the behavior of lesion growth in tissue.
There are, however, a few limitations to this model. First,
it is well established that temperature elevation of tissues
results in the denaturing of proteins, which may drasti-
cally change the electrical conductivity of tissue in a non-
linear fashion [51,57]. Preliminary data suggests that the
electrical conductivity substantially increases, which
would likely increase the rate of tissue damage. The results
of this study show that as a first order approximation the
conductivity of equivalent sodium chloride solutions pro-
duces results that are within 5% of the experimental
measurements. Although the phenomena described in
this reporting are applicable to different tissues, the result-
Table 5: Lesion Volume with 100% Normal Tissue Perfusion. Values represent the total volume of tissue necroses calculated over the 
course of the simulated ablation using various cell damage thresholds (D) and isothermal temperatures (IT).
Source Voltage 
(Volts)
D = 63% (mm3) D = 100% (mm3) IT = 42°C (mm3)1 IT = 47°C (mm3)1 IT = 60°C (mm3)I T  =  9 0 ° C  ( m m 3)
2 . 5 000000
5 . 0 000000
7 . 5 000000
1 0 . 0 001000
12.5 0 0 47 0 0 0
15.0 0 0 185 6 0 0
17.5 0 0 358 68 0 0
20.0 4 2 513 177 1 0
22.5 23 19 784 287 15 0
25.0 131 89 1068 488 107 0
27.5 251 222 1502 759 241 3
30.0 433 364 2014 1064 423 24
1 – The 42°C and 47°C isothermal volumes were chosen specifically because they are frequently used to establish damage thresholds in 
hyperthermia and radiofrequency ablation, respectively.
Table 6: Lesion Dimensions with no Tissue Perfusion Values represent the maximum lesion width and depth calculated over the course 
of the simulated ablation using various cell damage thresholds (D) and isothermal temperatures (IT).
Width (mm) Depth (mm)
Source Voltage 
(Volts)
D = 63% D = 100% IT = 42°C1 IT = 47°C1 IT = 60°C IT = 90°C D = 63% D = 100% IT = 42°C1 IT = 47°C1 IT = 60°C IT = 90°C
2 . 50 00 00 0 0 00 00 0
5 . 00 00 00 0 0 00 00 0
7 . 50 00 00 0 0 00 00 0
10.0 0 0 8 0 0 0 0 0 19 0 0 0
12.5 0 0 16 0 0 0 0 0 26 0 0 0
15.0 0 0 22 8 0 0 0 0 31 13 0 0
17.5 6 4 28 14 4 0 7 5 35 24 6 0
20.0 10 8 32 18 10 0 21 16 39 28 18 0
22.5 14 12 36 22 14 0 25 24 43 31 24 0
25.0 18 18 40 26 18 4 28 26 45 34 28 6
27.5 22 22 44 30 22 8 31 30 49 37 30 14
30.0 26 26 46 34 26 12 33 33 51 39 33 23
1 – The 42°C and 47°C isothermal volumes were chosen specifically because they are frequently used to establish damage thresholds in 
hyperthermia and radiofrequency ablation, respectively.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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ing lesion dimensions and temperature profiles in this
study apply only to liver tissue. Similar studies can be
made in other tissues, but were not pursued in this study.
A second limitation in our model is that it is only valid for
temperatures below 100°C. At temperatures above
100°C, tissues begin to boil and generate gas. When this
occurs, some of the energy that contributes to temperature
increase is used to change the water content of tissues into
gas. At substantially higher temperatures, the composition
of gas may be highly complex as tissue begins to burn and
break down. Although gas generation is commonly seen
in clinical use of radiofrequency ablation, impedance rises
due to tissue charring limit the progressive rise in
temperature. The complexity of multi-phasic ablation was
beyond the scope of this study.
Disclaimer
The mention of commercial products, their sources, or
their use in connection with material reported herein is
not to be construed as either an actual or implied endorse-
ment of such products by the Department of Health and
Human Services.
Table 7: Lesion Volume with 100% Normal Tissue Perfusion Values represent the maximum lesion width and depth calculated over the 
course of the simulated ablation using various cell damage thresholds (D) and isothermal temperatures (IT).
Width Depth
Source 
Voltage 
(Volts)
D = 63% D = 
100%
IT = 
42°C1
IT = 
47°C1
IT = 
60°C
IT = 
90°C
D = 63% D = 
100%
IT = 
42°C1
IT = 
47°C1
IT = 
60°C
IT = 
90°C
2 . 5 000000000000
5 . 0 000000000000
7 . 5 000000000000
1 0 . 0 002000002000
1 2 . 5 00800000 1 6 000
1 5 . 0 00 1 0 00000 2 5 000
1 7 . 5 00 1 4 60000 2 7 700
2 0 . 0 4 41 68 2 0 5 42 9 2 32 0
2 2 . 5 6 62 0 1 06 01 083 1 2 58 0
25.0 10 8 24 14 8 0 23 23 33 27 23 0
27.5 12 12 26 18 12 4 25 25 36 29 25 5
30.0 16 14 30 20 16 6 27 27 38 31 27 9
1 – The 42°C and 47°C isothermal volumes were chosen specifically because they are frequently used to establish damage thresholds in 
hyperthermia and radiofrequency ablation, respectively.
Table 8: Comparison of Computational Data to Experimental Validation Data at 22°C.
Lesion Width Lesion Depth
Source Voltage (Volts) D = 63% (mm) Experimental (mm) D = 63% (mm) Experimental (mm)
2 0 . 0 0000
22.5 0 -- 0 --
2 5 . 0 4556
27.5 8 -- 9 --
30.0 10 10 21 22
Simulated lesion dimensions with no tissue perfusion at an ambient temperature of 22°C using a 63% cell damage threshold (D) were compared to 
experimental measurements made at 20, 25, and 30 volts using an experimental constant voltage radiofrequency ablation source. Lesions were 
generated with a single needle ablation probe with a 2.0 cm active electrode. All lesion measurements were measured visually under a micrsope at 
10× magnification.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
Page 17 of 19
(page number not for citation purposes)
Experimental validation radiofrequency ablation lesions in excised porcine liver tissue produced by a 20 volt (left) and 30 volt  (right) constant voltage radiofrequency generator (500 kHz) for a 15 minute exposure time Figure 11
Experimental validation radiofrequency ablation lesions in excised porcine liver tissue produced by a 20 volt (left) and 30 volt 
(right) constant voltage radiofrequency generator (500 kHz) for a 15 minute exposure time. The lesions were produced using 
a single needle ablation probe with a 2 centimeter uninsulated tip.BioMedical Engineering OnLine 2004, 3:27 http://www.biomedical-engineering-online.com/content/3/1/27
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